Status:
COMPLETED
Longitudinal Outcomes of Hearing Aids
Lead Sponsor:
Yu-Hsiang Wu
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Presbycusis
Eligibility:
All Genders
55-85 years
Phase:
NA
Brief Summary
Age-related hearing loss is a substantial national problem due to its high prevalence and significant psychosocial consequences. Although hearing aids (HAs) are the primary intervention for the manage...
Detailed Description
Although hearing aids (HAs) are the first treatment of choice for age-related hearing loss, only 15-30% of those older Americans who could benefit, actually seek HAs out and use them. HA adoption rate...
Eligibility Criteria
Inclusion
- adult-onset, bilateral, mild-to-moderately severe sensorineural hearing loss
Exclusion
- Non-native speaker of English
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04030299
Start Date
September 1 2019
End Date
September 1 2022
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242